Erchen Plus Huiyanzhuyu Decoction Inhibits the Growth of Laryngeal Carcinoma in a Mouse Model of Phlegm-Coagulation-Blood-Stasis Syndrome Via the STAT3/Cyclin D1 Pathway

Overview

Journal Evid Based Complement Alternat Med

Specialty Rehabilitation Medicine

Date 2020 May 9

PMID 32382281

Citations 7

Authors

Xi Tan

Qiulan Luo

Shiqing Zhou

Wei Huang

Xiaocong Feng

Wenyong Chen

Chaojie Yang

Yunying Li

Affiliations

Soon will be listed here.

Abstract

Erchen plus Huiyanzhuyu decoction (EHD), a Chinese herbal medicine (CHM) formula that consists of Erchen decoction and Huiyanzhuyu decoction, has achieved satisfactory results in the clinic. The main function of EHD is to remove phlegm and blood stasis, and EHD is suitable for phlegm-coagulation-blood-stasis (PCBS) syndrome in laryngeal cancer (LC). In this study, a xenograft mouse model of LC with PCBS syndrome was constructed by feeding a high-fat diet, swimming in ice water, and subcutaneously injecting epinephrine hydrochloride for 2 weeks. Based on the successful Chinese medicine syndrome model, Hep2-luciferase-GFP cells were injected subcutaneously under the armpit of the right upper limb in mice to form tumours. A mouse model of LC with PCBS syndrome was established via heterotopic transplantation. Then, the mice received intragastric administration of different concentrations of EHD daily, and cisplatin (DDP) was intraperitoneally injected every week for 21 days. Tumour fluorescence in mice was measured with a living animal imager on days 7, 14, 21, and 28 during treatment. The results of this experiment confirmed that a mouse model of Chinese medicine syndrome was successfully constructed. Moreover, EHD slowed the growth of xenograft tumours in nude mice; decreased the expression levels of STAT3, p-STAT3, and cyclin D1; and upregulated the expression level of P27. In brief, EHD inhibited laryngeal tumour growth in a xenograft mouse model of PCBS syndrome and regulated the STAT3/cyclin D1 signalling pathway. This study was the first to construct a Chinese medicine xenograft mouse model of LC with PCBS syndrome; in addition, this study clarified that EHD regulated the STAT3/cyclin D1 signalling pathway to inhibit the growth of LC and that EHD may be a promising novel therapeutic compound for the treatment of patients with LC.

Citing Articles

Experimental Verification of Erchen Decoction Plus Huiyanzhuyu Decoction in the Treatment of Laryngeal Squamous Cell Carcinoma Based on Network Pharmacology.

Tan X, Luo Q, Hua Y, Zhou S, Peng G, Zhu R Integr Cancer Ther. 2024; 23:15347354241259182.

PMID: 38845538 PMC: 11159533. DOI: 10.1177/15347354241259182.

A chronic stress-induced microbiome perturbation, highly enriched in , promotes colorectal cancer growth and metastasis.

Zhao L, Hou X, Feng Y, Zhang Y, Shao S, Wu X Int J Med Sci. 2024; 21(5):882-895.

PMID: 38617000 PMC: 11008488. DOI: 10.7150/ijms.90612.

Integrating GEO, network pharmacology, and in vitro assays to explore the pharmacological mechanism of Bruceae Fructus against laryngeal cancer.

Wu Z, Zhu Z, Fu L Naunyn Schmiedebergs Arch Pharmacol. 2023; 397(6):4165-4181.

PMID: 38032489 PMC: 11111496. DOI: 10.1007/s00210-023-02869-9.

Therapeutic Potential of Nanomedicine in Management of Alzheimer's Disease and Glioma.

Anwar F, Al-Abbasi F, Naqvi S, Sheikh R, Alhayyani S, Asseri A Int J Nanomedicine. 2023; 18:2737-2756.

PMID: 37250469 PMC: 10211371. DOI: 10.2147/IJN.S405454.

Regulation of Fatty Acid Metabolism and Inhibition of Colorectal Cancer Progression by Erchen Decoction.

Liao L, Zhang F, Zhuo Z, Huang C, Zhang X, Liu R Evid Based Complement Alternat Med. 2023; 2023:9557720.

PMID: 37078067 PMC: 10110375. DOI: 10.1155/2023/9557720.

References

Huynh J, Chand A, Gough D, Ernst M . Therapeutically exploiting STAT3 activity in cancer - using tissue repair as a road map. Nat Rev Cancer. 2018; 19(2):82-96. DOI: 10.1038/s41568-018-0090-8. View

Ozdemir Y, Topkan E . Second primary malignancies in laryngeal carcinoma patients treated with definitive radiotherapy. Indian J Cancer. 2019; 56(1):29-34. DOI: 10.4103/ijc.IJC_273_18. View

Chen C, Cen L, Kohout J, Hutzen B, Chan C, Hsieh F . Signal transducer and activator of transcription 3 activation is associated with bladder cancer cell growth and survival. Mol Cancer. 2008; 7:78. PMC: 2577686. DOI: 10.1186/1476-4598-7-78. View

Tao L, Huang G, Wang R, Pan Y, He Z, Chu X . Cancer-associated fibroblasts treated with cisplatin facilitates chemoresistance of lung adenocarcinoma through IL-11/IL-11R/STAT3 signaling pathway. Sci Rep. 2016; 6:38408. PMC: 5138853. DOI: 10.1038/srep38408. View

Zhang S, Xin H, Li Y, Zhang D, Shi J, Yang J . Skimmin, a Coumarin from Hydrangea paniculata, Slows down the Progression of Membranous Glomerulonephritis by Anti-Inflammatory Effects and Inhibiting Immune Complex Deposition. Evid Based Complement Alternat Med. 2013; 2013:819296. PMC: 3748779. DOI: 10.1155/2013/819296. View

Calo V, Migliavacca M, Bazan V, Macaluso M, Buscemi M, Gebbia N . STAT proteins: from normal control of cellular events to tumorigenesis. J Cell Physiol. 2003; 197(2):157-68. DOI: 10.1002/jcp.10364. View

Dupla D, Fraczek M, Krecicki T, Wozniak Z . [Prognostic significance of cyclin D1 and cyclin B expression in laryngeal squamous cell carcinomas treated with radiotherapy]. Otolaryngol Pol. 2009; 63(2):136-40. DOI: 10.1016/S0030-6657(09)70094-0. View

Gao L, Xu D, Wen L, Zhang X, Shao Y, Zhao X . Inhibition of STAT3 expression by siRNA suppresses growth and induces apoptosis in laryngeal cancer cells. Acta Pharmacol Sin. 2005; 26(3):377-83. DOI: 10.1111/j.1745-7254.2005.00053.x. View

Kopparam J, Chiffelle J, Angelino P, Piersigilli A, Zangger N, Delorenzi M . RIP4 inhibits STAT3 signaling to sustain lung adenocarcinoma differentiation. Cell Death Differ. 2017; 24(10):1761-1771. PMC: 5596425. DOI: 10.1038/cdd.2017.81. View

10.

Fathi N, Rashidi G, Khodadadi A, Shahi S, Sharifi S . STAT3 and apoptosis challenges in cancer. Int J Biol Macromol. 2018; 117:993-1001. DOI: 10.1016/j.ijbiomac.2018.05.121. View

11.

Tamaki A, Miles B, Lango M, Kowalski L, Zender C . AHNS Series: Do you know your guidelines? Review of current knowledge on laryngeal cancer. Head Neck. 2017; 40(1):170-181. DOI: 10.1002/hed.24862. View

12.

Liu T, Peng H, Zhang M, Deng Y, Wu Z . Cucurbitacin B, a small molecule inhibitor of the Stat3 signaling pathway, enhances the chemosensitivity of laryngeal squamous cell carcinoma cells to cisplatin. Eur J Pharmacol. 2010; 641(1):15-22. DOI: 10.1016/j.ejphar.2010.04.062. View

13.

Aggarwal B, Sethi G, Ahn K, Sandur S, Pandey M, Kunnumakkara A . Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution. Ann N Y Acad Sci. 2007; 1091:151-69. DOI: 10.1196/annals.1378.063. View

14.

Lloyd R, Erickson L, Jin L, Kulig E, Qian X, Cheville J . p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am J Pathol. 1999; 154(2):313-23. PMC: 1850003. DOI: 10.1016/S0002-9440(10)65277-7. View

15.

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View

16.

Leslie K, Lang C, Devgan G, Azare J, Berishaj M, Gerald W . Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3. Cancer Res. 2006; 66(5):2544-52. DOI: 10.1158/0008-5472.CAN-05-2203. View

17.

Meng L, Liu C, Lu J, Zhao Q, Deng S, Wang G . Small RNA zippers lock miRNA molecules and block miRNA function in mammalian cells. Nat Commun. 2017; 8:13964. PMC: 5216115. DOI: 10.1038/ncomms13964. View

18.

Bowman T, Garcia R, Turkson J, Jove R . STATs in oncogenesis. Oncogene. 2000; 19(21):2474-88. DOI: 10.1038/sj.onc.1203527. View

19.

Sen Z, Jie M, Jingzhi Y, Dongjie W, Dongming Z, Xiaoguang C . Total Coumarins from Protect against Cisplatin-Induced Acute Kidney Damage in Mice by Suppressing Renal Inflammation and Apoptosis. Evid Based Complement Alternat Med. 2017; 2017:5350161. PMC: 5358452. DOI: 10.1155/2017/5350161. View

20.

Zhang L, Xu Y, Ge Y, Yu Y, Yu L . [Expression of p27 protein and cyclinD1 in laryngeal carcinoma]. Lin Chuang Er Bi Yan Hou Ke Za Zhi. 2003; 16(12):646-7. View